Vaccination for sexual abuse victims, immunocompromised individuals, and transplant recipients
DOI:
https://doi.org/10.5327/2237-4574-2024810008Keywords:
human papillomavirus, vaccines, cancerAbstract
Vaccination against HPV is crucial in preventing infections and various types of cancer, including cervical, anal, vulvar, vaginal, penile, and some head and neck cancers. Vaccination guidelines vary for specific groups, such as victims of sexual abuse, immunocompromised individuals, and transplant recipients. For sexual abuse victims, vaccination is essential due to the high risk of HPV exposure, protecting against the development of related cancers. Immunocompromised individuals, such as those with HIV/AIDS, have a higher risk of HPV infection and complications, although in some cases, the effectiveness of vaccination has not been fully demonstrated. Transplant recipients, despite a possible reduction in vaccine efficacy due to immune suppression, also benefit from vaccination to prevent infections and related cancers. Vaccination is most effective when administered before virus exposure. Therefore, it's important to follow specific guidelines for age and medical condition, as well as continue regular screening exams after vaccination.
References
Garland SM, Subasinghe AK, Jayasinghe YL, Wark JD, Moscicki AB, Singer A, et al. HPV vaccination for victims of childhood sexual abuse. Lancet. 2015;386(10007):1919-20. https://doi.org/10.1016/s0140-6736(15)00757-6
Human Papillomavirus Vaccination: ACOG Committee Opinion Summary, Number 809. Obstet Gynecol. 2020;136(2):435-6. https://doi.org/10.1097/aog.0000000000004001
Jayasinghe YL, Sasongko V, Lim RW, Grover SR, Tabrizi SN, Moore EE, et al. The association between unwanted sexual experiences and early-onset cervical cancer and precancer by age 25: a case-control study. J Womens Health (Larchmt). 2017;26(7):774-87. https://doi.org/10.1089/jwh.2016.5742
Goodman E, Reuschenbach M, Kaminski A, Ronnebaum S. Human papillomavirus vaccine impact and effectiveness in six high-risk populations: a systematic literature review. Vaccines (Basel). 2022;10(9):1543. https://doi.org/10.3390/vaccines10091543
Silverberg MJ, Leyden WA, Lam JO, Chao CR, Gregorich SE, Huchko MJ, et al. Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women. Vaccine. 2020 Jun 15;38(29):4520-23. https://doi.org/10.1016/j.vaccine.2020.05.004
Boey L, Curinckx A, Roelants M, Derdelinckx I, Van Wijngaerden E, Munter P, et al. Immunogenicity and safety of the 9-valent human papillomavirus vaccine in solid organ transplant recipients and adults infected with human immunodeficiency virus (HIV). Clin Infect Dis. 2021;73(3):e661-71. https://doi.org/10.1093/cid/ciaa1897
